Jeffrey B. Landau - 19 Mar 2024 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Jeffrey B Landau
Issuer symbol
CTMX
Transactions as of
19 Mar 2024
Net transactions value
-$13,685
Form type
4
Filing time
21 Mar 2024, 16:36:46 UTC
Previous filing
19 Jan 2024
Next filing
22 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Sale $13,685 -6,562 -5.6% $2.09 110,060 19 Mar 2024 Direct F1, F2
holding CTMX Common Stock 4,500 19 Mar 2024 Fidelity Traditional IRA
holding CTMX Common Stock 3,180 19 Mar 2024 Schwab ROTH IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 64,802 restricted stock units.